| 8 | An HIV 1/2 point of care test on sputum for screening TB/HIV coinfection in central India-Will it work?显示文摘Objective:To determine whether the OraQuick(?).HIV-1/2 Assay(OraSure Technologies, Inc.,Bethlehem,PA,USA) in sputum is a valid tool for HIV surveillance among TB patients. Methods:A cross sectional study was carried out on sputa of patients diagnosed with tuberculosis.Sputa were tested for antibodies to HIV using OraQuick. HIV-1/2 Assay(OraSure Technologies,Inc.,Bethlehem,PA,USA).The results were compared with results of serum ELISA.Results:Compared to serum ELISA,the OraQuick(?).HIV-1/2 Assay in sputum specimens reported 90%sensitivity(9/10)and 100%specificity(307/307),with a positive predictive value of 100%(95%CI:66.37%-100.00%)and a negative predictive value of 99.68%(95%CI:98.20%-99.99%). Conclusions:This testing method may provide a useful strategy for conducting HIV surveillance in possible co-infected TB patients at peripheral centres.Since there is no investment on infrastructure,it may be possible for paramedical health professionals to carry out the test. particularly in areas with low HIV endemicity. | Prabha Desikan Sajal De Nitika Pant Pai Pradyumna K Mishra Kaushal Kumar Nikita Panwalkar Mayanka Verma Zia Ul Hasan Kewal K Maudar | 2013 | Asian Pacific Journal of Tropical Medicine2013，6，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员